Research ArticleClinical Investigations
18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome
Bianca A.W. Hoeben, Esther G.C. Troost, Paul N. Span, Carla M.L. van Herpen, Johan Bussink, Wim J.G. Oyen and Johannes H.A.M. Kaanders
Journal of Nuclear Medicine April 2013, 54 (4) 532-540; DOI: https://doi.org/10.2967/jnumed.112.105999
Bianca A.W. Hoeben
1Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Esther G.C. Troost
1Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Paul N. Span
1Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Carla M.L. van Herpen
2Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; and
Johan Bussink
1Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Wim J.G. Oyen
3Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Johannes H.A.M. Kaanders
1Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 4
April 1, 2013
18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome
Bianca A.W. Hoeben, Esther G.C. Troost, Paul N. Span, Carla M.L. van Herpen, Johan Bussink, Wim J.G. Oyen, Johannes H.A.M. Kaanders
Journal of Nuclear Medicine Apr 2013, 54 (4) 532-540; DOI: 10.2967/jnumed.112.105999
18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome
Bianca A.W. Hoeben, Esther G.C. Troost, Paul N. Span, Carla M.L. van Herpen, Johan Bussink, Wim J.G. Oyen, Johannes H.A.M. Kaanders
Journal of Nuclear Medicine Apr 2013, 54 (4) 532-540; DOI: 10.2967/jnumed.112.105999
Jump to section
Related Articles
Cited By...
- FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab
- Imaging-Based Treatment Adaptation in Radiation Oncology
- Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
- PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging
- 111In-Cetuximab-F(ab')2 SPECT and 18F-FDG PET for Prediction and Response Monitoring of Combined-Modality Treatment of Human Head and Neck Carcinomas in a Mouse Model
- Early Response Monitoring with 18F-FDG PET and Cetuximab-F(ab')2-SPECT After Radiotherapy of Human Head and Neck Squamous Cell Carcinomas in a Mouse Model
- PET Imaging During Radiotherapy of Head and Neck Cancer